| Hemophilia |
1 |
1 |
| Immunization |
0 |
1 |
| COVID-19 Vaccine |
0 |
0.91 |
| COVID-19 |
0 |
0.65 |
| Vaccines |
0 |
0.52 |
| Severe Acute Respiratory Syndrome |
0 |
0.41 |
| Biologic Therapy |
0 |
0.36 |
| Patient Safety |
0 |
0.36 |
| Acute Respiratory Distress Syndrome |
0 |
0.32 |
| Hemophilia A |
0 |
1 |
| Pregnancy |
0 |
0.18 |
| Autoimmune Disease |
0 |
0.16 |
| Adverse Effects |
0 |
0.08 |
| Antineoplastic Drug |
0 |
0.08 |
| Coagulation |
0 |
0.08 |
| Factor VIII |
0 |
0.08 |
| Immunosuppressive Therapy |
0 |
0.08 |
| Monoclonal Antibody |
0 |
0.08 |
| Pandemic |
0 |
0.08 |
| Postpartum |
0 |
0.08 |
| Prognosis |
0 |
0.08 |
| Rare Diseases |
0 |
0.08 |
| Remission |
0 |
0.08 |
| Steroids |
0 |
0.08 |
| Stress |
0 |
0.08 |
| Thrombosis |
0 |
0.08 |
| Sepsis |
0 |
0.07 |
| Thromboembolism |
0 |
0.07 |